TORRENT PHARMA at All Time High; BSE HEALTHCARE Index Down 0.7%
February 17, 2020 12:14 PM

TORRENT PHARMA share price has hit an all-time high at Rs 2,154 (up 1.9%).

Meanwhile, the BSE HEALTHCARE Index is at 14,483 (down 0.7%).

Among the top gainers in the BSE HEALTHCARE Index today are TORRENT PHARMA (up 1.9%) and DR. REDDYS LAB (up 0.5%).

ABBOTT INDIA (down 0.2%) and SYNGENE INTERNATIONAL (down 0.2%) are among the top losers today.

Over the last one year, TORRENT PHARMA has moved up from Rs 1,771 to Rs 2,154, registering a gain of Rs 383 (up 21.6%).

The BSE HEALTHCARE has moved up from 13,744 to 14,483, registering a gain of 739 points (up 4.1%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were GRANULES INDIA (up 106.4%), ABBOTT INDIA (up 93.8%) and J.B.CHEMICALS (up 81.6%).

What About the Benchmark Indices?

The BSE Sensex is at 41,420 (down 0.1%). The top gainers among the BSE Sensex stocks today are TITAN (up 1.6%), INDUSIND BANK (up 1.6%) and TATA STEEL (up 1.2%). Other gainers include NESTLE (up 0.9%) and TCS (up 0.7%). The most traded stocks in the BSE Sensex are TATA STEEL and INDUSIND BANK.

In the meantime, NSE Nifty is at 12,160 (down 0.2%). The top gainers in the NSE Nifty include INDUSIND BANK (up 1.7%), TITAN (up 1.5%) and VEDANTA LTD (up 1.3%). Other gainers include TATA STEEL (up 1.1%) and NESTLE (up 0.9%).

Over the last 12 months, the BSE Sensex has moved up from 35,876 to 41,420, registering a gain of 5,544 points (up 14.9%).

TORRENT PHARMA Financial Update...

TORRENT PHARMA net profit stood at Rs 3 billion for the quarter ended December 2019, compared to a profit of Rs 2 billion a year ago. Net Sales declined 4.1% to Rs 19.7 billion during the period as against Rs 20.5 billion in October-December 2018.

For the year ended March 2019, TORRENT PHARMA reported 17.0% increase in net profit to Rs 7.9 billion compared to net profit of Rs 6.8 billion during FY18.

Revenue of the company grew 29.0% to Rs 77 billion during FY19.

The current Price to earnings ratio of TORRENT PHARMA, based on rolling 12 month earnings, stands at 65.2x.